CLINICAL_TRIALS
research
· 2026-04-22
Clinical Trial Update: Ketamine, SGB and Combination Treatment for TBI [Phase 2]
Summary
A Phase 2 clinical trial from Northwestern University is evaluating ketamine with stellate ganglion block and a combination approach for traumatic brain injury,…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Posttraumatic Headache, Posttraumatic Stress Disorder | Phase 2 | Status: RECRUITING